Seriousness and Causality in Pharmacovigilance: Two Judgements That Drive Every Report

Seriousness decides how fast a case must be reported. Causality decides whether it is reported at all. Both are judgements, both are often done in a hurry, and both are routinely misunderstood.

Seriousness is not severity

An event is serious if it meets a regulatory criterion, not because it feels severe. The ICH criteria are death, life-threatening, hospitalisation or prolongation of existing hospitalisation, persistent or significant disability or incapacity, and a congenital anomaly or birth defect. Events that do not meet these but are medically important can also be treated as serious, with the EMA’s list of important medical events serving as a reference for the judgement. A severe headache is not serious by default. A mild event that leads to admission is.

Where teams go wrong on seriousness

  • Counting a planned admission for a pre-existing condition as a seriousness criterion.
  • Treating “life-threatening” as meaning any event that could in theory have been fatal, when the criterion refers to the patient being at risk of death at the time of the event.
  • Not recording the criterion that was applied, which makes later review impossible.
  • Downgrading seriousness between initial and follow-up reports without a documented reason.

Causality: a reasonable possibility

In the post-authorisation setting, a case is reported when there is at least a reasonable possibility of a causal relationship between the product and the event. For spontaneous reports, an event reported by a healthcare professional or consumer is generally regarded as suspected unless the reporter says otherwise. The company may add its own assessment, but should not use it to override the reporter’s view in order to avoid reporting. Where the reporter has given no opinion, the company assesses on the available information, typically considering temporal relationship, dechallenge and rechallenge, alternative explanations, and known pharmacology.

Documenting the reasoning

Structured algorithms can help consistency, but the real value is in the written rationale. A good causality statement names the facts it relies on and the facts it lacks. “Unlikely related due to alternative aetiology” is much more useful if the alternative is named. Where information is missing, the response is usually a follow-up request rather than a guess, and the open question should be visible in the case.

Consistency across the portfolio

Medical reviewers should apply the same logic to the same type of case. Periodic review of a sample of cases by a second physician, and a short set of examples agreed in-house, are inexpensive ways to keep assessments aligned.

How PQRA helps

PQRA supports the writing of seriousness and causality conventions, medical review checklists and training material, and can carry out an independent review of a sample of cases to test for consistency. For smaller holders we can also provide experienced reviewers within a defined service.

Contact PQRA to discuss your pharmacovigilance system, in Greece and across the EU.

CATEGORIES:

Uncategorized

Tags:

No responses yet

Αφήστε μια απάντηση

Η ηλ. διεύθυνση σας δεν δημοσιεύεται. Τα υποχρεωτικά πεδία σημειώνονται με *